Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation
- 1 September 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 335 (2-3) , 205-209
- https://doi.org/10.1016/s0014-2999(97)01237-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteriesBritish Journal of Pharmacology, 1997
- Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bedBritish Journal of Pharmacology, 1997
- Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing FactorsCirculation Research, 1996
- Inhibitors of the cytochrome P450‐mono‐oxygenase and endothelium‐dependent hyperpolarizations in the guinea‐pig isolated carotid arteryBritish Journal of Pharmacology, 1996
- Cytochrome P450-dependent effects of bradykinin in the rat heartBritish Journal of Pharmacology, 1995
- Characterization of endothelium‐derived hyperpolarizing factor as a cytochrome P450‐derived arachidonic acid metabolite in mammals.The Journal of Physiology, 1994
- Display of the characteristics of endothelium‐derived hyperpolarizing factor by a cytochrome P450‐derived arachidonic acid metabolite in the coronary microcirculationBritish Journal of Pharmacology, 1994
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium‐derived relaxing factorBritish Journal of Pharmacology, 1991